Microbes in Health and Disease: Human Gut Microbiota
Source abstract
Abstract
Humans and microbes (e.g., bacteria, fungi, and microalgae) have coexisted and coevolved toward reciprocal adaptation. As omics technologies have rapidly advanced, the relevance of microbes to human health and disease as well as other fields has been progressively unraveled. This review focuses on the human gut microbiota, which is an emerging focus of microbiological research. This review synthesizes recent advances in exploring the fundamentals and multiple functions of the human gut microbiota and its associations with human health and diseases as well as microbiota-targeted therapies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Gut microbiota and health · Clostridium difficile and Clostridium perfringens research · Diet and metabolism studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmacy, University of Houston, Houston, TX 77204, USA
Donghu Experimental Station of Lake Ecosystems, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China
Funding
Special Project on National Science and Technology Basic Resources Investigation of China · CERN long-term observation data mining and annual data report
References (100+)
Show source-provided references
1. Scaling laws predict global microbial diversity10.1073/pnas.1521291113 ↗
2. Singh, R.L. (2017). Microbes and Environment. Principles and Applications of Environmental Biotechnology for a Sustainable Future, Springer.10.1007/978-981-10-1866-4 ↗
3. Parapouli, M., Vasileiadis, A., Afendra, A.S., and Hatziloukas, E. (2020). Saccharomyces cerevisiae and its industrial applications. AIMS Microbiol., 6.10.3934/microbiol.2020001 ↗
4. Biofertilizers function as key player in sustainable agriculture by improving soil fertility, plant tolerance and crop productivity10.1186/1475-2859-13-66 ↗
5. Review on Applied Applications of Microbiome on Human Lives10.3390/bacteria3030010 ↗
6. Industrial production of beta-lactam antibiotics10.1007/s00253-003-1274-y ↗
7. Bala, S., Garg, D., Thirumalesh, B.V., Sharma, M., Sridhar, K., Inbaraj, B.S., and Tripathi, M. (2022). Recent Strategies for Bioremediation of Emerging Pollutants: A Review for a Green and Sustainable Environment. Toxics, 10.10.3390/toxics10080484 ↗
8. Microbiota in health and diseases10.1038/s41392-022-00974-4 ↗
9. The biomass distribution on Earth10.1073/pnas.1711842115 ↗
10. Sender, R., Fuchs, S., and Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol., 14.10.1101/036103 ↗
11. A review on microalgae cultivation and harvesting, and their biomass extraction processing using ionic liquids10.1080/21655979.2020.1711626 ↗
12. pH determines the energetic efficiency of the cyanobacterial CO2 concentrating mechanism10.1073/pnas.1525145113 ↗
13. Estimates of global cyanobacterial biomass and its distribution10.1127/1864-1318/2003/0109-0213 ↗
14. The modern concept of the procaryote10.1128/JB.00962-08 ↗
15. Alleman, A.B., and Peters, J.W. (2023). Mechanisms for Generating Low Potential Electrons across the Metabolic Diversity of Nitrogen-Fixing Bacteria. Appl. Environ. Microbiol., 89.10.1128/aem.00378-23 ↗
16. Sepp, S.K., Vasar, M., Davison, J., Oja, J., Anslan, S., Al-Quraishy, S., Bahram, M., Bueno, C.G., Cantero, J.J., and Fabiano, E.C. (2023). Global diversity and distribution of nitrogen-fixing bacteria in the soil. Front. Plant Sci., 14.10.3389/fpls.2023.1100235 ↗
17. Oxidation of reduced inorganic sulfur compounds by bacteria: Emergence of a common mechanism?10.1128/AEM.67.7.2873-2882.2001 ↗
18. Kushkevych, I., Prochazka, J., Gajdacs, M., Rittmann, S.K.R., and Vitezova, M. (2021). Molecular Physiology of Anaerobic Phototrophic Purple and Green Sulfur Bacteria. Int. J. Mol. Sci., 22.10.3390/ijms22126398 ↗
19. Yang, Q., Yao, H., Liu, S., and Mao, J. (2021). Interaction and Application of Molds and Yeasts in Chinese Fermented Foods. Front. Microbiol., 12.10.3389/fmicb.2021.664850 ↗
20. Conventional and Innovative Processing of Milk for Yogurt Manufacture; Development of Texture and Flavor: A Review10.3390/foods3010176 ↗
21. Trotta, T., Porro, C., Cianciulli, A., and Panaro, M.A. (2022). Beneficial Effects of Spirulina Consumption on Brain Health. Nutrients, 14.10.3390/nu14030676 ↗
22. Gulig, P., Swindle, S., Fields, M., and Eisenman, D. (2024). A Review of Clinical Trials Involving Genetically Modified Bacteria, Bacteriophages and Their Associated Risk Assessments. Appl. Biosaf.10.1089/apb.2024.0002 ↗
23. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease10.1016/j.cgh.2006.03.028 ↗
24. Ortiz-Velez, L., Goodwin, A., Schaefer, L., and Britton, R.A. (2020). Challenges and Pitfalls in the Engineering of Human Interleukin 22 (hIL-22) Secreting Lactobacillus reuteri. Front. Bioeng. Biotechnol., 8.10.3389/fbioe.2020.00543 ↗
25. Bioremediation of environmental organic pollutants by Pseudomonas aeruginosa: Mechanisms, methods and challenges10.1016/j.envres.2023.117211 ↗
26. The Human Microbiome Project10.1007/s12088-012-0304-9 ↗
27. Interaction between microbiota and immunity in health and disease10.1038/s41422-020-0332-7 ↗
28. Microbiota medicine: Towards clinical revolution10.1186/s12967-022-03296-9 ↗
29. Bacteriophages of the Human Gut: The “Known Unknown” of the Microbiome10.1016/j.chom.2019.01.017 ↗
30. Enterotypes of the human gut microbiome10.1038/nature09944 ↗
31. The human gut and groundwater harbor non-photosynthetic bacteria belonging to a new candidate phylum sibling to Cyanobacteria10.7554/eLife.01102 ↗
32. Hu, C., and Rzymski, P. (2022). Non-Photosynthetic Melainabacteria (Cyanobacteria) in Human Gut: Characteristics and Association with Health. Life, 12.10.3390/life12040476 ↗
33. A human gut microbial gene catalogue established by metagenomic sequencing10.1038/nature08821 ↗
34. Diversity of the human gastrointestinal tract microbiota revisited10.1111/j.1462-2920.2007.01369.x ↗
35. Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.10.3390/microorganisms7010014 ↗
36. Nash, A.K., Auchtung, T.A., Wong, M.C., Smith, D.P., Gesell, J.R., Ross, M.C., Stewart, C.J., Metcalf, G.A., Muzny, D.M., and Gibbs, R.A. (2017). The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome, 5.10.1186/s40168-017-0373-4 ↗
37. Fungal microbiota dysbiosis in IBD10.1136/gutjnl-2015-310746 ↗
38. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice10.1126/scitranslmed.aaf9044 ↗
39. Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function10.1111/joim.13307 ↗
40. Immunology of diseases associated with Malassezia species10.1128/CMR.15.1.21-57.2002 ↗
41. Spatz, M., and Richard, M.L. (2020). Overview of the Potential Role of Malassezia in Gut Health and Disease. Front. Cell Infect. Microbiol., 10.10.3389/fcimb.2020.00201 ↗
42. Ciurea, C.N., Kosovski, I.B., Mare, A.D., Toma, F., Pintea-Simon, I.A., and Man, A. (2020). Candida and Candidiasis-Opportunism Versus Pathogenicity: A Review of the Virulence Traits. Microorganisms, 8.10.3390/microorganisms8060857 ↗
43. Alonso-Monge, R., Gresnigt, M.S., Roman, E., Hube, B., and Pla, J. (2021). Candida albicans colonization of the gastrointestinal tract: A double-edged sword. PLoS Pathog., 17.10.1371/journal.ppat.1009710 ↗
44. Candida gut commensalism and inflammatory disease10.1016/j.medmic.2020.100008 ↗
45. Nam, Y.D., Jung, M.J., Roh, S.W., Kim, M.S., and Bae, J.W. (2011). Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing. PLoS ONE, 6.10.1371/journal.pone.0022109 ↗
46. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies10.1038/s41586-022-05546-8 ↗
47. Microbiota succession throughout life from the cradle to the grave10.1038/s41579-022-00768-z ↗
48. The composition of the gut microbiota throughout life, with an emphasis on early life
49. Programming infant gut microbiota: Influence of dietary and environmental factors10.1016/j.copbio.2010.03.020 ↗
50. Population-level analysis of gut microbiome variation10.1126/science.aad3503 ↗
51. Sidhu, S.R.K., Kok, C.W., Kunasegaran, T., and Ramadas, A. (2023). Effect of Plant-Based Diets on Gut Microbiota: A Systematic Review of Interventional Studies. Nutrients, 15.10.3390/nu15061510 ↗
52. Zhou, X., Qiao, K., Wu, H., and Zhang, Y. (2023). The Impact of Food Additives on the Abundance and Composition of Gut Microbiota. Molecules, 28.10.3390/molecules28020631 ↗
53. Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V.L., and Cohen, H. (2020). Antibiotics as Major Disruptors of Gut Microbiota. Front. Cell Infect. Microbiol., 10.10.3389/fcimb.2020.572912 ↗
54. Plant-based diets and the gut microbiome: Findings from the Baltimore Longitudinal Study of Aging10.1016/j.ajcnut.2024.01.006 ↗
55. The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity10.1007/s00394-019-02161-8 ↗
56. Systematic evaluation of antimicrobial food preservatives on glucose metabolism and gut microbiota in healthy mice10.1038/s41538-022-00158-y ↗
57. Patangia, D.V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., and Stanton, C. (2022). Impact of antibiotics on the human microbiome and consequences for host health. Microbiologyopen, 11.10.1002/mbo3.1260 ↗
58. Antibiotic perturbations to the gut microbiome10.1038/s41579-023-00933-y ↗
59. Formation of propionate and butyrate by the human colonic microbiota10.1111/1462-2920.13589 ↗
60. Gut microbiota functions: Metabolism of nutrients and other food components10.1007/s00394-017-1445-8 ↗
61. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection10.1128/MMBR.00007-19 ↗
62. Colonic Microflora: Nutrition and Health. Summary and Conclusions of an International Life Sciences Institute (ILSI) [Europe] Workshop held in Barcelona, Spain10.1111/j.1753-4887.1995.tb01535.x ↗
63. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism10.1080/19490976.2015.1134082 ↗
64. Sending signals—The microbiota’s contribution to intestinal epithelial homeostasis10.1016/j.micinf.2020.10.009 ↗
65. Roles of intestinal epithelial cells in the maintenance of gut homeostasis10.1038/emm.2017.20 ↗
66. Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions10.2527/jas.50965 ↗
67. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose10.1152/ajpgi.00219.2004 ↗
68. Takakuwa, A., Nakamura, K., Kikuchi, M., Sugimoto, R., Ohira, S., Yokoi, Y., and Ayabe, T. (2019). Butyric Acid and Leucine Induce alpha-Defensin Secretion from Small Intestinal Paneth Cells. Nutrients, 11.10.3390/nu11112817 ↗
69. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT310.1038/mi.2017.118 ↗
70. Park, J.H., Kotani, T., Konno, T., Setiawan, J., Kitamura, Y., Imada, S., Usui, Y., Hatano, N., Shinohara, M., and Saito, Y. (2016). Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids. PLoS ONE, 11.10.1371/journal.pone.0156334 ↗
71. Parada Venegas, D., De la Fuente, M.K., Landskron, G., Gonzalez, M.J., Quera, R., Dijkstra, G., Harmsen, H.J.M., Faber, K.N., and Hermoso, M.A. (2019). Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol., 10.10.3389/fimmu.2019.01486 ↗
72. Role of the microbiota in immunity and inflammation10.1016/j.cell.2014.03.011 ↗
73. Kennedy, E.A., King, K.Y., and Baldridge, M.T. (2018). Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Front. Physiol., 9.10.3389/fphys.2018.01534 ↗
74. Interactions between commensal intestinal bacteria and the immune system10.1038/nri1373 ↗
75. The role of IL-10 in microbiome-associated immune modulation and disease tolerance10.1016/j.cyto.2014.11.027 ↗
76. The gut microbiota shapes intestinal immune responses during health and disease10.1038/nri2515 ↗
77. Delves, P.J. (1998). Germ-Free Animals. Encyclopedia of Immunology, Elsevier. [2nd ed.].
78. The intestinal microflora in allergic Estonian and Swedish 2-year-old children10.1046/j.1365-2222.1999.00560.x ↗
79. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: An update10.1111/j.1365-2249.2010.04139.x ↗
80. Wang, J., Zhu, N., Su, X., Gao, Y., and Yang, R. (2023). Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis. Cells, 12.10.3390/cells12050793 ↗
81. Induction of intestinal Th17 cells by segmented filamentous bacteria10.1016/j.cell.2009.09.033 ↗
82. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway10.1038/mi.2014.44 ↗
83. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior10.1093/ijnp/pyw020 ↗
84. The Microbiota-Gut-Brain Axis10.1152/physrev.00018.2018 ↗
85. The gut microbiota-brain axis in behaviour and brain disorders10.1038/s41579-020-00460-0 ↗
86. Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., and Okamoto, A. (2015). Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease. PLoS ONE, 10.10.1371/journal.pone.0142164 ↗
87. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis10.1007/s00406-014-0502-z ↗
88. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells10.1096/fj.14-259598 ↗
89. Miri, S., Yeo, J., Abubaker, S., and Hammami, R. (2023). Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?. Front. Microbiol., 14.10.3389/fmicb.2023.1098412 ↗
90. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis10.1016/j.cell.2015.02.047 ↗
91. The gut microbiota, HPA axis, and brain in adolescent-onset depression: Probiotics as a novel treatment10.1016/j.bbih.2022.100541 ↗
92. Misiak, B., Loniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., and Samochowiec, J. (2020). The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?. Prog. Neuropsychopharmacol. Biol. Psychiatry, 102.10.1016/j.pnpbp.2020.109951 ↗
93. Host microbiota constantly control maturation and function of microglia in the CNS10.1038/nn.4030 ↗
94. Microglia and early brain development: An intimate journey10.1126/science.aat0474 ↗
95. The Gut Microbiome as a Regulator of the Neuroimmune Landscape10.1146/annurev-immunol-101320-014237 ↗
96. Control of brain development, function, and behavior by the microbiome10.1016/j.chom.2015.04.011 ↗
97. The Gut-Brain Axis10.1146/annurev-med-042320-014032 ↗
98. Gut microbial molecules in behavioural and neurodegenerative conditions10.1038/s41583-020-00381-0 ↗
99. Almeida, C., Oliveira, R., Soares, R., and Barata, P. (2020). Influence of gut microbiota dysbiosis on brain function: A systematic review. Porto Biomed. J., 5.10.1097/j.pbj.0000000000000059 ↗
100. Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., Harding, S.J., Merluzzi, A.P., Johnson, S.C., Carlsson, C.M., Asthana, S., Zetterberg, H., and Blennow, K. (2017). Gut microbiome alterations in Alzheimer’s disease. Sci. Rep., 7.10.1038/s41598-017-13601-y ↗